A nutrient combination designed to enhance synapse formation and function improves outcome in experimental spinal cord injury

Neurobiology of Disease

Volumn 82, Issue , 2015, Pages 504-515

  Pallier, Patrick N ^a   Poddighe, Laura ^b   Zbarsky, Virginia ^a   Kostusiak, Milosz ^a   Choudhury, Rasall ^a   Hart, Thomas ^a   Burguillos, Miguel A ^a   Musbahi, Omar ^a   Groenendijk, Martine ^c   Sijben, John W ^c   deWilde, Martijn C ^c   Quartu, Marina ^b   Priestley, John V ^a   Michael Titus, Adina T ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c Nutricia Nederland   (Netherlands)

Author keywords

Dietary supplementation; Fortasyn connect; Neuroplasticity; Neuroprotection; Spinal cord injury

Indexed keywords

FORTASYN; NEUROPROTECTIVE AGENT; PROTEOCHONDROITIN SULFATE; UNCLASSIFIED DRUG; DOCOSAHEXAENOIC ACID; FORTASYN CONNECT; ICOSAPENTAENOIC ACID; PHOSPHOLIPID;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTOSIS; BLADDER FUNCTION; CELL ACTIVATION; CELL SURVIVAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIET THERAPY; DRUG MECHANISM; EXPERIMENTAL SPINAL CORD INJURY; FEMALE; FUNCTIONAL STATUS; LOCOMOTION; MICROGLIA; NERVE FIBER; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; NUTRIENT; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT; SYNAPTOGENESIS; TREATMENT DURATION; TREATMENT OUTCOME; ANIMAL; ASTROCYTE; BLADDER; CELL DEATH; CONVALESCENCE; DIETARY SUPPLEMENT; DISEASE MODEL; GLIOSIS; IMMUNOLOGY; MOTOR ACTIVITY; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; SCAR; SPINAL CORD; SPINAL CORD INJURY; SPRAGUE DAWLEY RAT; THORACIC VERTEBRA; WISTAR RAT;

ANIMALS; ASTROCYTES; CELL DEATH; CELL SURVIVAL; CICATRIX; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FEMALE; GLIOSIS; MOTOR ACTIVITY; NEURONS; OLIGODENDROGLIA; PHOSPHOLIPIDS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECOVERY OF FUNCTION; SPINAL CORD; SPINAL CORD INJURIES; THORACIC VERTEBRAE; TREATMENT OUTCOME; URINARY BLADDER;

EID: 84947031635     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2015.09.007     Document Type: Article

References (66)

1. Anderson D., Hall E. Pathophysiology of spinal cord trauma. Ann. Emerg. Med. 1993, 22:987-992.
2. Basso D.M. Behavioral testing after spinal cord injury: congruities, complexities, and controversies. J. Neurotrauma 2004, 21(4):395-404.
3. Basso D.M., Beattie M.S., Bresnahan J.C. A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 1995, 12:1-21.
4. Basso D.M., Beattie M.S., Bresnahan J.C. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp. Neurol. 1996, 139(2):244-256.
5. Behrmann D.L., Bresnahan J.C., Beattie M.S., Shah B.R. Spinal cord injury produced by consistent mechanical displacement of the cord in rats: behavioral and histologic analysis. J. Neurotrauma 1992, 9(3):197-217.
6. Bresnahan J.C., Beattie M.S., Stokes B.T., Conway K.M. Three-dimensional computer-assisted analysis of graded contusion lesions in the spinal cord of the rat. J. Neurotrauma 1991, 8(2):91-101.
7. Cansev M., Wurtman R.J. Chronic administration of docosahexaenoic acid or eicosapentaenoic acid, but not arachidonic acid, alone or in combination with uridine, increases brain phosphatide and synaptic protein levels in gerbils. Neuroscience 2007, 148(2):421-431.
8. Cansev M., Marzloff G., Sakamoto T., Ulus I.H., Wurtman R.J. Giving uridine and/or docosahexaenoic acid orally to rat dams during gestation and nursing increases synaptic elements in brains of weanling pups. Dev. Neurosci. 2009, 31(3):181-192.
9. Cansev M., van Wijk N., Turkyilmaz M., Orhan F., Sijben J.W., Broersen L.M. A specific multi-nutrient enriched diet enhances hippocampal cholinergic transmission in aged rats. Neurobiol. Aging 2015, 36(1):344-351.
10. Cansev M., Wurtman R.J., Sakamoto T., Ulus I.H. Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses. Alzheimers Dement. 2008, 4(1 Suppl. 1):S153-S168.
11. Darios F., Davletov B. Omega-3 and omega-6 fatty acids stimulate cell membrane expansion by acting on syntaxin 3. Nature 2006, 440(7085):813-817.
12. Eidelberg E., Story J.L., Walden J.G., Meyer B.L. Anatomical correlates of return of locomotor function after partial spinal cord lesions in cats. Exp. Brain Res. 1981, 42(1):81-88.
13. Fehlings M.G., Tator C.H. The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury. Exp. Neurol. 1995, 132(2):220-228.
14. Fernyhough P., Gallagher A., Averill S.A., Priestley J.V., Hounsom L., Patel J., et al. Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy. Diabetes 1999, 48:881-889.
15. Ferreira A., Rapoport M. The synapsins: beyond the regulation of neurotransmitter release. Cell. Mol. Life Sci. 2002, 59(4):589-595.
16. Fraser C., McIntyre A., Thompson S., Madady M., Teasell R.W. Nutrition issues following spinal cord injury. Spinal Cord Injury Rehabilitation Evidence 2014, (Version 5.0:1-32). J.J. Eng, R.W. Teasell, W.C. Miller, D.L. Wolfe, A.F. Townson, H. JTC (Eds.).
17. Holguin S., Huang Y., Liu J., Wurtman R.J. Chronic administration of DHA and UMP improves the impaired memory of environmentally impoverished rats. Behav. Brain Res. 2008, 191(1):11-16.
18. Holguin S., Martinez J., Chow C., Wurtman R.J. Dietary uridine enhances the improvement in learning and memory produced by administering DHA to gerbils. FASEB J. 2008, 22(11):3938-3946.
19. Horn K.P., Busch S.A., Hawthorne A.L., van Rooijen N., Silver J. Another barrier to regeneration in the CNS: activated macrophages induce extensive retraction of dystrophic axons through direct physical interactions. J. Neurosci. 2008, 28(38):9330-9341.
20. Huang W.L., George K., Ibba V., Liu M., Averill S.A., Quartu M., et al. The characteristics of neuronal injury in a static compression model of spinal cord injury in adult rats. Eur. J. Neurosci. 2007, 25:362-372.
21. Huang W.L., King V.R., Curran O.E., Dyall S.C., Ward R.E., Lal N., et al. A combination of intravenous and dietary docosahexaenoic acid significantly improves outcome after spinal cord injury. Brain 2007, 130:3004-3019.
22. Iskandar B.J., Nelson A., Resnick D., Skene J.H., Gao P., Johnson C., et al. Folic acid supplementation enhances repair of the adult central nervous system. Ann. Neurol. 2004, 56(2):221-227.
23. Iwasaki Y., Yamamoto H., Iizuka H., Yamamoto T., Konno H. Suppression of neurofilament degradation by protease inhibitors in experimental spinal cord injury. Brain Res. 1987, 406:99-104.
24. Jansen D., Zerbi V., Arnoldussen I.A.C., Wiesmann M., Rijpma A., Fang X.T., et al. Effects of specific multi-nutrient enriched diets on cerebral metabolism, cognition and neuropathology in AßPPswe-PS1dE9 mice. PLoS One 2013, 8(9).
25. Katoh D., Ikata T., Katoh S., Hamada Y., Fukuzawa K. Effect of dietary vitamin C on compression injury of the spinal cord in a rat mutant unable to synthesize ascorbic acid and its correlation with that of vitamin E. Spinal Cord 1996, 34(4):234-238.
26. Kennedy E.P., Weiss S.B. The function of cytidine coenzymes in the biosynthesis of phospholipids. J. Biol. Chem. 1956, 222:192-214.
27. Kim B.G., Dai H.N., McAtee M., Vicini S., Bregman B.S. Remodeling of synaptic structures in the motor cortex following spinal cord injury. Exp. Neurol. 2006, 198(2):401-415.
28. King V.R., Huang W.L., Dyall S.C., Curran O.E., Priestley J.V., Michael-Titus A.T. Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat. J. Neurosci. 2006, 26:4672-4680.
29. Lankhorst A.J., Verzijl M.R., Hamers F.P.T. Experimental spinal cord contusion injury: comparison of different outcome parameters. Neurosci. Res. Commun. 1999, 24(3):135-148.
30. Lemke M., Yum S.W., Faden A.I. Lipid alterations correlate with tissue magnesium decrease following impact trauma in rabbit spinal cord. Mol. Chem. Neuropathol. 1990, 12(3):147-165.
31. Lim S.N., Gladman S.J., Dyall S.C., Patel U., Virani N., Kang J.X., et al. Transgenic mice with high endogenous omega-3 fatty acids are protected from spinal cord injury. Neurobiol. Dis. 2013, 51:104-112.
32. Lim S.N., Huang W.L., Ward R.E., Hall J., Priestley J.V., Michael-Titus A.T. The acute administration of eicosapentaenoic acid is neuroprotective after spinal cord compression injury in rats. Prostag. Leukot. Ess. 2010, 83:193-201.
33. Liu Z.-H., Yip P.K., Adams L., Davies M., Lee J.W., Michael G.J., et al. A single bolus of docosahexaenoic acid promotes neuroplastic changes in the innervation of spinal cord interneurons and motor neurons and improves functional recovery after spinal cord injury. J. Neurosci. 2015, 35(37):12,733-12,752.
34. Loy D.N., Talbott J.F., Onifer S.M., Mills M.D., Burke D.A., Dennison J.B., et al. Both dorsal and ventral spinal cord pathways contribute to overground locomotion in the adult rat. Exp. Neurol. 2002, 177(2):575-580.
35. Manack A., Motsko S.P., Haag-Molkenteller C., Dmochowski R.R., Goehring E.L., Nguyen-Khoa B.A., et al. Epidemiology and healthcare utilization of neurogenic bladder patients in a US claims database. Neurourol. Urodyn. 2011, 30:395-401.
36. McTigue D.M., Tripathi R., Wei P., Lash A.T. The PPAR gamma agonist Pioglitazone improves anatomical and locomotor recovery after rodent spinal cord injury. Exp. Neurol. 2007, 205(2):396-406.
37. van Middendorp J.J., Allison H., Cowan K. Top ten research priorities for spinal cord injury. Lancet Neurol. 2014, 13:1167.
38. Mills C.D., Hains B.C., Johnson K.M., Hulsebosch C.E. Strain and model differences in behavioral outcomes after spinal cord injury in rats. J. Neurotrauma 2001, 18(8):743-756.
39. Nystrom B., Berglund J.E., Bergquist E. Methodological analysis of an experimental spinal cord compression model in the rat. Acta Neurol. Scand. 1988, 78:460-466.
40. Petchkrua W., Burns S.P., Stiens S.A., James J.J., Little J.W. Prevalence of vitamin B12 deficiency in spinal cord injury. Arch. Phys. Med. Rehabil. 2003, 84(11):1675-1679.
41. Popovich P., Guan Z., Wei P., Huitinga I., van Rooijen N., Stokes B. Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp. Neurol. 1999, 158:351-365.
42. Priestley J.V., Michael-Titus A.T., Tetzlaff W. Limiting spinal cord injury by pharmacological intervention. Handb. Clin. Neurol. 2012, 109:463-484.
43. Profyris C., Cheema S., Zang D., Azari M., Boyle K., Petratos S. Degenerative and regenerative mechanisms governing spinal cord injury. Neurobiol. Dis. 2004, 15:415-436.
44. Ray S.K., Matzelle D.D., Wilford G.G., Hogan E.L., Banik N.L. Cell death in spinal cord injury (SCI) requires de novo protein synthesis. Calpain inhibitor E-64-d provides neuroprotection in SCI lesion and penumbra. Ann. N. Y. Acad. Sci. 2001, 939:436-449.
45. Sakamoto T., Cansev M., Wurtman R.J. Oral supplementation with docosahexaenoic acid and uridine-5'-monophosphate increases dendritic spine density in adult gerbil hippocampus. Brain Res. 2007, 1182:50-59.
46. Scheltens P., Kamphuis P.J., Verhey F.R., Olde Rikkert M.G., Wurtman R.J., Wilkinson D., et al. Efficacy of a medical food in mild Alzheimer's disease: a randomized, controlled trial. Alzheimers Dement. 2010, 6(1):1-10.
47. Scheltens P., Twisk J.W., Blesa R., Scarpini E., von Arnim C.A., Bongers A., et al. Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial. J. Alzheimers Dis. 2012, 31(1):225-236.
48. Schucht P., Raineteau O., Schwab M.E., Fouad K. Anatomical correlates of locomotor recovery following dorsal and ventral lesions of the rat spinal cord. Exp. Neurol. 2002, 176(1):143-153.
49. Schumacher P.A., Siman R.G., Fehlings M.G. Pretreatment with calpain inhibitor CEP-4143 inhibits calpain I activation and cytoskeletal degradation, improves neurological function, and enhances axonal survival after traumatic spinal cord injury. J. Neurochem. 2000, 7:1646-1655.
50. Sekhon L.H., Fehlings M.G. Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine 2001, (Suppl. 26):S2-12.
51. Taoka Y., Ikata T., Fukuzawa K. Influence of dietary vitamin E deficiency on compression injury of rat spinal cord. J. Nutr. Sci. Vitaminol. 1990, 36(3):217-226.
52. Teather L.A., Magnusson J.E., Chow C.M., Wurtman R.J. Environmental conditions influence hippocampus-dependent behaviours and brain levels of amyloid precursor protein in rats. Eur. J. Neurosci 2002, 16(12):2405-2415.
53. Van Wijk N., Broersen L.M., de Wilde M.C., Hageman R.J.J., Groenandijk M., Sijben J.W.C., et al. Targeting synaptic dysfunction in Alzheimer's disease by administering a specific nutrient combination. J. Alzheimers Dis. 2014, 38:459-479.
54. de Waal H., Stam C.J., Lansbergen M.M., Wieggers R.L., Kamphuis P.J., Scheltens P., et al. The effect of souvenaid on functional brain network organisation in patients with mild Alzheimer's disease: a randomised controlled study. PLoS One 2014, 9(1).
55. Wang L., Pooler A.M., Albrecht M.A., Wurtman R.J. Dietary uridine-5'-monophosphate supplementation increases potassium-evoked dopamine release and promotes neurite outgrowth in aged rats. J. Mol. Neurosci. 2005, 27(1):137-145.
56. Wanner I.B., Anderson M.A., Song B., Levine J., Fernandez A., Gray-Thompson Z., et al. Glial scar borders are formed by newly proliferated, elongated astrocytes that interact to corral inflammatory and fibrotic cells via STAT3-dependent mechanisms after spinal cord injury. J. Neurosci. 2013, 33(31):12,870-12,886.
57. Ward R.E., Huang W.L., Curran O.E., Priestley J.V., Michael-Titus A.T. Docosahexaenoic acid prevents white matter damage after spinal cord injury. J. Neurotrauma 2010, 27(10):1769-1780.
58. Ward R.E., Huang W.L., Kostusiak M., Pallier P.N., Michael-Titus A.T., Priestley J.V. A characterization of white matter pathology following spinal cord compression injury in the rat. Neuroscience 2014, 260:227-239.
59. 42-induced toxicity in rats. J. Alzheimers Dis. 2011, 27:237-239.
60. Wurtman R.J., Cansev M., Ulus I.H. Synapse formation is enhanced by oral administration of uridine and DHA, the circulating precursors of brain phosphatides. J. Nutr. Health Aging 2009, 13(3):189-197.
61. Wurtman R.J., Cansev M., Sakamoto T., Ulus I.H. Use of phosphatide precursors to promote synaptogenesis. Annu. Rev. Nutr. 2009, 29:59-87.
62. Wurtman R.J., Ulus I.H., Cansev M., Watkins C.J., Wang L., Marzloff G. Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally. Brain Res. 2006, 1088(1):83-92.
63. Yeo J.E., Kim J.H., Kang S.K. Selenium attenuates ROS-mediated apoptotic cell death of injured spinal cord through prevention of mitochondria dysfunction; in vitro and in vivo study. Cell. Physiol. Biochem. 2008, 21(1-3):225-238.
64. Yin Y., Henzl M.T., Lorber B., Nakazawa T., Thomas T.T., Jiang F., et al. Oncomodulin is a macrophage-derived signal for axon regeneration in retinal ganglion cells. Nat. Neurosci. 2006, 9(6):843-852.
65. Yiu G., He Z.G. Glial inhibition of CNS axon regeneration. Nat. Rev. Neurosci. 2006, 7:617-612.
66. Young W. Spinal cord regeneration. Cell Transplant. 2014, 23(4-5):573-611.